Partner Sites

Clinical Chemistry

Increased cardiometabolic testing for adults with diabetes, and all adults in the case of Lp(a), will translate to many millions of additional laboratory tests across the US in the coming years.
|3 min read

Trends in Cardiometabolic Testing: Lipoprotein(a) and Natriuretic Peptide Testing

Fully automated platforms and diagnostics partnerships are essential for clinical labs to manage increasing cardiometabolic test volumes
byAlex Fohl, PharmD
Emerging Technologies Guide: Fall 2025
|4 min read

Emerging Technologies Guide: Fall 2025

Recent new and emerging technologies in the field of laboratory medicine from the 2025 September Pathogen Detection & Infectious Disease issue of Today's Clinical Lab
byToday's Clinical Lab
The United States reported 209,253 total syphilis cases and 3,882 congenital syphilis cases in 2023.
|2 min read

One Dose of Antibiotic Treats Early Syphilis as Well as Three Doses

NIH-funded clinical trial shows potential to simplify treatment for early syphilis
byNational Institutes of Health
Today's Clinical Lab 2025 Pathogen Detection & Infectious Disease print issue
|2 min read

'Reemerging Threats, Reimagined Strategies'

The Today's Clinical Lab 2025 Pathogen Detection & Infectious Disease print issue features smarter diagnostics, reemerging threats, and lab-driven strategies for tackling sepsis, measles, and C. difficile infections
byMiriam Bergeret, MSc
Scientists working in a clinical laboratory
|4 min read

How Analyte Specific Reagents Support Quality in Research and Diagnostic Labs

Designed for regulated use, ASR antibodies enable reproducible results and reliable test performance
bySarah Kirsh, MSc andBioLegend
Sponsored by
For patients with IBD, stopping medication leads to an increase in IBD symptoms, which can make their pregnancies high-risk.
|4 min read

First Global Guidelines for Pregnancy and Inflammatory Bowel Disease Developed

UCSF's Uma Mahadevan, MD, leads international consensus conference, with goal of improving treatment and outcomes for women with IBD and their children
byUniversity of California - San Francisco
Despite recent advances in immunotherapy and targeted therapies, many patients with metastatic renal cell carcinoma, an aggressive and often fatal form of kidney cancer, either fail to respond or eventually relapse.
|3 min read

UCLA Researchers Develop Off-the-Shelf Immunotherapy for Metastatic Kidney Cancer

Approach offers a promising next-generation strategy for treating metastatic renal cell carcinoma
byUniversity of California - Los Angeles
Despite the alarming statistics, many sepsis-related deaths are preventable through rapid diagnosis and treatment.
|4 min read

Challenges and Advances in Sepsis Detection

FDA-approved tests like Intellisep and TriVerity™ demonstrate potential for early sepsis diagnosis
byZahraa Chorghay, PhD
Gloved hand holding dry reagent cup
|1 min read

Reimagining Immunoassay Testing: The Case for Dry Reagent Systems

Explore how dry reagent immunoassays can reduce waste, simplify workflows, and support high-throughput lab efficiency without compromising accuracy
byToday's Clinical Lab andTosoh Bioscience
Sponsored by
The new range provides users with greater options when designing spectral flow cytometry panels.
|1 min read

Bio-Rad Expands Range of StarBright Dyes to Enhance Panel Design Capabilities for Spectral Flow Cytometry

New range of StarBright™ dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
byBio-Rad Laboratories
This marks a significant milestone for clinical laboratories in the United States.
Updated |2 min read

AliveDx's MosaiQ® Platform Registered with FDA as Class II 510(k) Exempt, Enabling US Labs to Adopt High-Throughput Automated Immunoassay Testing

MosaiQ is a next-gen immunoassay platform delivering automated, multiplexed testing and actionable insights for complex conditions
byAliveDx
Lyme disease, a tick-transmitted infection that is principally caused by the spirochete Borrelia burgdorferi in the United States and closely related species in Europe, has become the most common vector-borne disease in the US.
|3 min read

New Single-Tier Lyme Disease Test Shows Over 90 Percent Sensitivity in Early Diagnosis

Unlike standard two-tier protocols, the assay uses a dual-antigen binding approach to improve early detection accuracy and may offer a more efficient workflow for clinical labs
byKephera Diagnostics
Page 7 of 132
34567891011

Sponsored

Social

Your Model From Our Experience: Cloud First Digital Pathology in a High-Volume Regional Laboratory  

Sponsored by
A clinician holds a AI chip surrounded by digital healthcare icons, representing the use of artificial intelligence in clinical diagnostics

Ensuring Compliance: How to Get AI Diagnostic Tools Approved for Clinical Practice

Sponsored by
Two researchers working in a diagnostic lab with advanced testing solutions

Cutting-Edge Gastrointestinal Pathogen Testing Technologies for Labs

Sponsored by
Screenshot

The Path to Absolute Quantification in Gene Expression

Sponsored by